We have previously demonstrated that a plasma membrane-enriched fracti
on isolated from human liver is capable of binding recombinant hepatit
is B surface antigen (rHBsAg) (P. Pontisso, M. A. Petit, M. Bankowski,
and M. E. Peeples, J. Virol. 63:1981-1988, 1989). In this study we ha
ve separated the plasma membrane proteins by sodium dodecyl sulfate-po
lyacrylamide gel electrophoresis and used a ligand-blotting technique
to identify a 46-kDa rHBsAg-binding protein. This protein could be rem
oved from the membranes with a weakly acidic buffer, implying that it
is peripherally bound. Examination of human serum revealed that the 46
-kDa binding protein is a serum protein. Isolation of plasma lipoprote
ins revealed that the binding protein is in part associated with chylo
microns and high-density lipoproteins, both of which are targeted to t
he hepatocyte during the normal course of lipid metabolism. The bindin
g protein was identified as apolipoprotein H (apo H), also known as be
ta 2-glycoprotein I, on the basis of copurification of the rHBsAg-bind
ing activity with the apo H protein and the ability of cDNA-expressed
apo H to bind rHBsAg. Serum-derived HBsAg also binds to apo H, indicat
ing that binding is not unique to rHBsAg. Binding is saturable, requir
es only the small S protein of rHBsAg, and is inhibited by excess rHBs
Ag, antibodies to HBsAg, and antibodies to apo H. The binding activity
of apo H is destroyed upon reduction, indicating that 1 or more of it
s 22 disulfide bonds are required for interaction with rHBsAg. The pos
sibility that an interaction between hepatitis B virus particles and l
ipoprotein particles may facilitate entry of the virus into hepatocyte
s is discussed.